Cymabay Therapeutics Inc (NASDAQ:CBAY)

3.46
Delayed Data
As of 3:59pm ET
 -0.31 / -8.22%
Today’s Change
3.34
Today|||52-Week Range
7.77
-39.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-15.5M-26.7M-27.6M-72.5M
 
 
 
 
 
Depreciation22.0K29.0K35.0K105.0K
 
 
 
 
 
Total Other Cash Flow-7.9M3.0M10.9M8.6M
 
 
 
 
 
Funds From Operations-23.4M-23.6M-16.6M-63.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-78.0K-290.0K3.0M-8.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-23.3M-23.4M-19.6M-54.9M
 
 
 
 
 
 
InvestingIncrease In Investments-42.8M-22.9M-98.4M-276.4M
 
 
 
 
 
Decrease In Investments31.7M50.1M30.9M222.8M
 
 
 
 
 
Capital Expenditures0.00-42.0K-27.0K-529.0K
 
 
 
 
Net Cash Flow Investing-11.1M27.1M-67.5M-54.1M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings9.5M0.000.000.00
 
 
Long Term Debt Reduction-4.8M-986.0K-3.1M-6.5M
 
 
 
 
 
Net Proceeds Stock Sale25.8M0.00102.9M141.6M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends--0.000.000.00--
Cash Dividends Paid - Total--0.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.00126.0K
 
 
Net Cash Flow - Financing30.5M-986.0K99.7M135.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-3.9M2.8M12.6M25.9M